Invitek Molecular acquired by ALS Limited

Working at als
19 JAN 2023
As a leading biotech company, Invitek Molecular has been providing tailored nucleic acid purification solutions for over three decades. Since our founding in 1992 in Berlin, Germany, we have specialized in the development and commercialization of manual and automated DNA/RNA extraction from various sample materials. Our expertise extends beyond this, as we also offer custom development and contract manufacturing services to in-vitro diagnostics companies globally, from concept to marketable product realization.
We are proud to announce that our technical reputation and experience have been recognized by ALS Limited, and we are now part of their diagnostics division, offering clients a complete one-stop-shop solution. This acquisition is a testament to ALS' commitment to growing their diagnostics capabilities and services and delivering robust solutions to their clients.